Navigation Links
Coalition for a Competitive Pharmaceutical Market Runs Ads Stating Congress Is Giving 'Greatest Holiday Gift of All to Brand Pharmaceutical Companies'
Date:12/17/2009

Urges the President to Tell Congress to Fix the Bill

WASHINGTON, Dec. 17 /PRNewswire-USNewswire/ -- Beginning Thursday, December 17th, the Coalition for a Competitive Pharmaceutical Market (CCPM) will launch a print and electronic ad campaign inside-the-Beltway and in select states charging that, during this holiday season, Congress is giving the "greatest holiday gift of all to brand pharmaceutical companies" by putting brand company profits before patients. The ads urge the President to tell Congress to fix the health care bills that currently restrict access to safe, effective and affordable generic and biogeneric medicines.

"We all want to see health care reform, but real reform means increased access to affordable medicines and reductions in cost. With generic medicines saving the health care system one billion dollars every three days, Congress should be increasing, not decreasing, access to affordable generic and biogeneric medicines," said Katie Huffard, executive director of the Coalition for a Competitive Pharmaceutical Market. "President Obama has expressed strong support for generic medicines and has favored a seven-year market exclusivity provision for biogenerics. We urge the President to tell Congress that to reduce health care costs while increasing access to quality care, lawmakers must fix health care reform legislation."

The following are texts of the TV, radio, print and banner ads from CCPM:

http://myhomefront.tv/clients/ccpm/advertisements.html

CCPM is an organization of large national employers, health plans, pharmacy benefit managers, chain pharmacies, generic drug manufacturers, biopharmaceutical manufacturers and others committed to improving consumer access to high quality, affordable generic medicines and promoting a vigorous, competitive prescription drug market.

CCPM supports public policies that facilitate timely access to affordable pharmaceuticals. Visit www.BiogenericsGetTheFacts.org for more information and a list of CCPM members.

GPhA Urges the White House and Congress to Heed Message of CCPM Health Care Reform Ad Campaign

The following is a statement from Kathleen Jaeger, President and CEO of the Generic Pharmaceutical Association (GPhA), on the new health care reform ad campaign from the Coalition for a Competitive Pharmaceutical Market (CCPM):

"During this holiday season, Congress is taking the phrase 'it is better to give than receive' very seriously when it comes to appeasing the brand drug companies. GPhA joins CCPM in calling upon President Obama to tell Congress that health care reform legislation must put patients before brand company profits.

"Currently, the health care reform bill is a treasure trove for brand pharmaceutical companies. It not only delays patient access to lifesaving biogeneric medicines, it encourages older Americans to use more costly brand drugs in the Medicare program. Meanwhile, generic medicines are saving our health care system one billion dollars every three days - $121 billion in 2008 alone. Moreover, a growing number of Americans are turning to safe and effective generic medicines to save money during these difficult economic times without compromising quality care. With generics, you get the same medicines as brand name drugs, but at much more affordable costs. Congress should be working to increase access to generic medicines, not restricting access.

"The generic pharmaceutical industry supports health care reform, but reform that puts patients, not brand company profits, come first. Our industry works every day to ensure that Americans are able to get the care they need at prices they can afford. We applaud the President for his strong support of generic medicines and his statements in favor of getting biogeneric medicines to patients sooner rather than later. Now, we need action from the President and Congress to fix this bill and ensure patient needs are a priority."

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. Generics represent 72% of the total prescriptions dispensed in the United States, but only 17% of all dollars spent on prescription drugs. For more information about the industry, visit www.gphaonline.org.

SOURCE Coalition for a Competitive Pharmaceutical Market


'/>"/>
SOURCE Coalition for a Competitive Pharmaceutical Market
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. AIDS Vaccine Advocacy Coalition Voices Disappointment in Trial Result
2. AIDS Vaccine Advocacy Coalition Calls for AIDS Vaccine Field to Work Together to Analyze STEP Study Data and Determine Best Course to Move Forward
3. Childhood Influenza Immunization Coalition Encourages Vaccination Throughout the Influenza Season
4. Cancer Cure Coalition Proposes Major Changes at the FDA
5. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
6. Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise
7. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
8. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
9. Competitive Technologies Selects RF
10. Binder as Public Relations Agency of Record
11. Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 9, 2016  Until recently, the ... surgery or liposuction. Thankfully, the FDA approved the non-invasive ... to death. Coolsculpting was originally approved in 2010 for ... thighs and now the chin. With this add-on approval, ... can use a smaller applicator, the CoolMini, to address ...
(Date:2/10/2016)... 2016 On Tuesday, February 9th, the ... with its Arthritis Advisory Committee to discuss ... & Johnson,s Remicade and most likely the ... U.S. The Biologics Prescribers Collaborative (BPC) along ... for Patient Access, American Association of Clinical ...
(Date:2/10/2016)... 2016 CTI BioPharma Corp. (CTI BioPharma) ... regarding the clinical studies being conducted under the ... Following the issuance of the Company,s February 8, ... issued by the U.S. Food and Drug Administration ... an oral communication from the FDA followed by ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... A national ergonomics pioneer ... Expo event March 9-11, 2016. Hosted by Ohio's Bureau of Worker's Compensation, the ... the longest running and largest worker's compensation event in Ohio, organizers of the ...
(Date:2/10/2016)... West Palm Beach, Florida (PRWEB) , ... February ... ... Golf & Country Club) announced that it has been awarded the prestigious Distinguished ... of the World award program conducted by BoardRoom magazine, one of the most ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has ... readily available to physicians. The integration will enable Allscripts users to post ... via Everseat’s free mobile app. , The partnership gives Everseat substantial added power ...
(Date:2/10/2016)... MA (PRWEB) , ... February 10, 2016 , ... ... their revolutionary, biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns combine ... provide a solution that ensures the integrity of biological samples while operating at ...
Breaking Medicine News(10 mins):